Vestcor Inc Biomarin Pharmaceutical Inc Transaction History

Vestcor Inc

$3.17 Billion
Q3 2024

A detailed history of Vestcor Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Vestcor Inc holds 3,699 shares of BMRN stock, worth $248,535. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,699

Previous 3,699 -0.0%

Holding current value

$248,535

Previous $305,000 14.75%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$83.81 - $99.0 $209,357 - $247,302	-2,498 Reduced 40.31%	3,699 $323,000
Q4 2023 Feb 14, 2024	SELL	$76.22 - $98.51 $3,277 - $4,235	-43 Reduced 0.69%	6,197 $598,000
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $49,851 - $55,365	-586 Reduced 8.58%	6,240 $552,000
Q2 2023 Aug 15, 2023	SELL	$86.68 - $100.3 $1.04 Million - $1.2 Million	-12,011 Reduced 63.76%	6,826 $592,000
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $4,825 - $6,449	-55 Reduced 0.29%	18,837 $1.83 Million
Q4 2022 Feb 15, 2023	BUY	$80.93 - $108.63 $1.18 Million - $1.58 Million	14,535 Added 333.6%	18,892 $1.96 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $6,162 - $7,270	75 Added 1.75%	4,357 $369,000
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $98,499 - $119,679	1,378 Added 47.45%	4,282 $355,000
Q1 2022 May 16, 2022	SELL	$74.28 - $92.69 $119,516 - $149,138	-1,609 Reduced 35.65%	2,904 $224,000
Q4 2021 Feb 15, 2022	SELL	$71.72 - $91.47 $49,773 - $63,480	-694 Reduced 13.33%	4,513 $399,000
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $25,870 - $29,572	-346 Reduced 6.23%	5,207 $402,000
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $230,229 - $258,524	3,049 Added 121.77%	5,553 $463,000
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $199,193 - $311,046	2,504 New	2,504 $309,000

Others Institutions Holding BMRN

# of Institutions

638

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestcor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vestcor Inc with notifications on news.

Account